Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.040x

Based on the latest financial reports, Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥227.64 Million ≈ $33.31 Million USD) by net assets (CN¥5.69 Billion ≈ $831.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Jingxin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Zhejiang Jingxin Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.

Zhejiang Jingxin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Jingxin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen Kingdom SCI Tech Co Ltd
SHG:600446
0.005x
Zhejiang Jingu Co Ltd
SHE:002488
0.004x
Solaria Energía y Medio Ambiente S.A
MC:SLR
0.024x
Stock Yards Bancorp Inc
NASDAQ:SYBT
0.051x
Beijing Sojo Electric Co Ltd
SHE:300444
-0.097x
AUB GROUP LTD.
F:A5H
N/A
China Sports Industry Group Co Ltd
SHG:600158
-0.011x
Guobang Pharma Ltd
SHG:605507
0.038x

Annual Cash Flow Conversion Efficiency for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see 002020 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥6.00 Billion
≈ $878.21 Million
CN¥726.16 Million
≈ $106.26 Million
0.121x -18.72%
2023-12-31 CN¥5.54 Billion
≈ $810.70 Million
CN¥824.69 Million
≈ $120.68 Million
0.149x -10.04%
2022-12-31 CN¥5.17 Billion
≈ $756.82 Million
CN¥855.78 Million
≈ $125.23 Million
0.165x +119.29%
2021-12-31 CN¥4.84 Billion
≈ $707.90 Million
CN¥365.02 Million
≈ $53.41 Million
0.075x -42.18%
2020-12-31 CN¥3.93 Billion
≈ $575.47 Million
CN¥513.21 Million
≈ $75.10 Million
0.130x -9.54%
2019-12-31 CN¥3.71 Billion
≈ $542.99 Million
CN¥535.30 Million
≈ $78.33 Million
0.144x -1.51%
2018-12-31 CN¥3.57 Billion
≈ $522.90 Million
CN¥523.40 Million
≈ $76.59 Million
0.146x +50.87%
2017-12-31 CN¥3.97 Billion
≈ $580.29 Million
CN¥385.01 Million
≈ $56.34 Million
0.097x -6.78%
2016-12-31 CN¥2.43 Billion
≈ $355.06 Million
CN¥252.69 Million
≈ $36.98 Million
0.104x +62.70%
2015-12-31 CN¥2.26 Billion
≈ $330.78 Million
CN¥144.69 Million
≈ $21.17 Million
0.064x -57.47%
2014-12-31 CN¥1.40 Billion
≈ $204.65 Million
CN¥210.49 Million
≈ $30.80 Million
0.151x +10.88%
2013-12-31 CN¥817.98 Million
≈ $119.70 Million
CN¥111.03 Million
≈ $16.25 Million
0.136x +73.98%
2012-12-31 CN¥772.58 Million
≈ $113.05 Million
CN¥60.28 Million
≈ $8.82 Million
0.078x -13.88%
2011-12-31 CN¥766.17 Million
≈ $112.11 Million
CN¥69.41 Million
≈ $10.16 Million
0.091x -51.30%
2010-12-31 CN¥320.13 Million
≈ $46.84 Million
CN¥59.55 Million
≈ $8.71 Million
0.186x -57.79%
2009-12-31 CN¥307.17 Million
≈ $44.95 Million
CN¥135.38 Million
≈ $19.81 Million
0.441x +345.67%
2008-12-31 CN¥303.19 Million
≈ $44.37 Million
CN¥29.98 Million
≈ $4.39 Million
0.099x +133.82%
2007-12-31 CN¥299.61 Million
≈ $43.84 Million
CN¥-87.60 Million
≈ $-12.82 Million
-0.292x -5856.81%
2006-12-31 CN¥294.62 Million
≈ $43.11 Million
CN¥-1.45 Million
≈ $-211.60K
-0.005x -102.30%
2005-12-31 CN¥289.64 Million
≈ $42.38 Million
CN¥61.82 Million
≈ $9.05 Million
0.213x +842.74%
2004-12-31 CN¥284.03 Million
≈ $41.56 Million
CN¥6.43 Million
≈ $940.95K
0.023x -95.66%
2003-12-31 CN¥88.44 Million
≈ $12.94 Million
CN¥46.18 Million
≈ $6.76 Million
0.522x -27.68%
2002-12-31 CN¥63.02 Million
≈ $9.22 Million
CN¥45.50 Million
≈ $6.66 Million
0.722x --

About Zhejiang Jingxin Pharmaceutical Co Ltd

SHE:002020 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.90 Billion
CN¥12.96 Billion CNY
Market Cap Rank
#6527 Global
#1509 in China
Share Price
CN¥15.05
Change (1 day)
+0.20%
52-Week Range
CN¥12.90 - CN¥21.63
All Time High
CN¥25.17
About

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemi… Read more